{
  "Johnson & Johnson": {
    "2025": {
      "FORM": "8-K",
      "CATEGORIES": {
        "Section 2 - Financial Information": {
          "ITEMS": {
            "Item 2.02 - Results of Operations and Financial Condition": {
              "content": "On April 15, 2025, Johnson & Johnson issued the attached press release (Exhibit 99.1) announcing its sales and earnings for the first quarter ended March 30, 2025.",
              "subsections": {}
            }
          }
        },
        "Section 8 - Other Events": {
          "ITEMS": {
            "Item 8.01 - Other Events": {
              "content": "On April 15, 2025, Johnson & Johnson issued the attached press release (Exhibit 99.3) announcing that its Board of Directors declared a 4.8% increase in the quarterly dividend, from $1.24 per share to $1.30 per share, marking the 63rd year of consecutive increases. At the new rate, the indicated dividend on an annual basis is $5.20 per share compared to the previous rate of $4.96 per share. The next quarterly dividend is payable on June 10, 2025 to shareholders of record at the close of business on May 27, 2025. The ex-dividend date is May 27, 2025.",
              "subsections": {}
            }
          }
        },
        "Section 9 - Financial Statements and Exhibits": {
          "ITEMS": {
            "Item 9.01 - Financial Statements and Exhibits": {
              "content": "(d) Exhibits.",
              "subsections": {
                "Exhibit_99.1": "Press Release dated April 15, 2025 for the period ended March 30, 2025",
                "Exhibit_99.2": "Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings for the fiscal first quarter",
                "Exhibit_99.3": "Press Release dated April 15, 2025",
                "Exhibit_104": "The cover page from this Current Report on Form 8-K, formatted in Inline XBRL."
              }
            }
          }
        }
      }
    }
  }
}